News | June 11, 2024
Abbott wins CE mark for dual-chamber leadless pacemaker
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023
His resignation would be effective from March 18, 2024
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care
Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity m system, which provides fast results in high volumes – detecting four infections simultaneously
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
